Research explores the kidney injury risks associated with lithium compared to valproate, revealing unexpected findings.

How do lithium and quetiapine compare in their ability to treat acute mania in children and teens? Are they effective? Do kids go into remission? And how do their side effect profiles compare?  This clinical update can help you decide which patients might be good candidates for which medication. 

Here we focus on the safe administration of lithium, discussing how to manage both common and lesser- known side effects so that you can ensure a comprehensive approach to your patients’ care.

Lithium’s reputation as a difficult med may have more to do with branding than reality, according to this large analysis of mood stabilizer adherence.

Lithium is FDA-approved for bipolar disorder in children and adolescents 12 years and up; however, its potential off-label utility is broad, from affective aggression to anorexia nervosa. This clinical update covers how to prescribe lithium for children and adolescents and how to talk with patients and parents about lithium. 

The management of bipolar disorder during pregnancy can be tricky. Some medications can be harmful to the fetus, and others need to be adjusted carefully due to changes in kidney and liver function. We walk you through the important considerations to keep in mind when working with these patients.